Pharmacists Prove their Worth in Diabetes Management

Pharmacists show why they need to be part of the “Diabetes Team” and the Ten City Challenge diabetes education program shows that they can also reduce costs ($1,079/patient) as well as reducing A1c levels along with cholesterol and blood pressure.

Medical and economic results from the Diabetes Ten City Challenge show significant benefits in patient health, lower healthcare costs—and higher pharmaceutical usage.

A collaborative effort among the American Pharmacists Assn. Foundation (APHA Foundation), a couple dozen employer-based health plans, and with financial support from GSK, called the Diabetes Ten City Challenge (DTCC), was initiated during 2005.  The goal was to evaluate the medical and economic benefits of active intervention in patient care, in the form of patient coaching by pharmacists.  Final economic and clinical results have just been published.

“It’s well known that diabetes is a national public health issue, with one of every five healthcare dollars being spent on it,” says William Ellis, executive director of the APHA Foundation and a coauthor of the study.  “DTCC shows that intervention results in improved patient health and lower overall insurance costs, and that the model of using pharmacists as coaches can work on a broad basis.”

The study comprised 573 patients, in ten cities nationally, whose employer-based plans agreed to cover the costs of medication co-pays and of interventions, over a two-year period ending in December 2007. (Overall data were normalized for one year for each individual patient.)

Statistically significant improvements were seen in A1c, cholesterol and blood pressure—all relevant to diabetes care, along with better vision testing and foot examinations patterns.  Factoring in the extra costs (of the coaching and other interventions, and of greater medications use), and comparing patient health costs to a projected level based on actual medical claims plus inflation, the study showed an overall savings of $1,079, or 7.4%, per patient, despite medication costs rising 32% over what had been projected. (Measurements of actual pharmaceutical consumption are not part of what APHA reported in the published study.)

“Larger-scale tests like these demonstrate the value of medication in managing chronic disease, which is a message that needs to be heard in Washington as well as in the healthcare system,” says Andy Hartsfield, VP of public policy and advocacy at GSK.  He says that the scale-up of the program (which traces back to the Asheville Project of the 1990’s) gives it national relevance.

Journal of the American Pharmacists Association, May/June 2009: 49: 49; e52-0.

===============================

Advertisement

A1cNow 10 or 20 Pack Test
A1CNow+ provides consistent, lab accurate results without the use of expensive capital equipment. Less than $10.00 per test.
https://www.a1ctest.com/